Hypothalamic Hamartoma: A Rare Cause of Precocious Puberty
Soufiane Benaazza *
Department of Radiology, Children’s Hospital, Rabat, Morocco.
Kenza Bentalha
Department of Radiology, Children’s Hospital, Rabat, Morocco.
Lina Belkouchi
Department of Radiology, Children’s Hospital, Rabat, Morocco.
Siham Elhaddad
Department of Radiology, Children’s Hospital, Rabat, Morocco.
Nazik Allali
Department of Radiology, Children’s Hospital, Rabat, Morocco.
Latifa Chat
Department of Radiology, Children’s Hospital, Rabat, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Aims: To highlight the characteristic magnetic resonance imaging (MRI) features of hypothalamic hamartoma and its role in the diagnosis of central precocious puberty in children.
Presentation of Case: A 9-year-old girl presented with progressive breast development, pubic hair growth, and accelerated linear growth. Clinical examination revealed Tanner stage IV development. Hormonal assessment showed elevated luteinizing hormone (0.92 IU/L) and estradiol (25 pg/mL), with normal follicle-stimulating hormone and 17-hydroxyprogesterone levels. Brain MRI demonstrated a small, well-circumscribed, non-enhancing lesion arising from the tuber cinereum, with signal intensity similar to grey matter and no mass effect on the optic chiasm or third ventricle. These findings were consistent with a hypothalamic hamartoma. The patient was treated with leuprorelin acetate, with favourable clinical and psychological evolution.
Discussion: Hypothalamic hamartoma is a rare congenital, non-neoplastic malformation and an important structural cause of central precocious puberty. Its characteristic MRI appearance, including its location, signal intensity, lack of enhancement, and absence of significant mass effect, usually allows a confident diagnosis and helps differentiate it from other suprasellar lesions.
Conclusion: Recognition of the typical MRI features of hypothalamic hamartoma is essential for accurate diagnosis and can prevent unnecessary invasive investigations. Early recognition also allows appropriate endocrine management and favourable clinical outcomes.
Keywords: Hypothalamic hamartoma, central precocious puberty, magnetic resonance imaging, tuber cinereum, Leuprorelin acetate, GnRH agonist, paediatric endocrinology, suprasellar lesion, tanner stage, bone age